SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001679082-21-000008
Filing Date
2021-02-11
Accepted
2021-02-11 06:57:18
Documents
16
Period of Report
2021-02-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K myov-20210211.htm   iXBRL 8-K 43802
2 EX-99.1 a12312020myovantex991.htm EX-99.1 129620
8 myovant161a.jpg GRAPHIC 14626
  Complete submission text file 0001679082-21-000008.txt   359295

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT myov-20210211.xsd EX-101.SCH 2421
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT myov-20210211_cal.xml EX-101.CAL 712
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT myov-20210211_def.xml EX-101.DEF 1649
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT myov-20210211_lab.xml EX-101.LAB 26105
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT myov-20210211_pre.xml EX-101.PRE 13676
9 EXTRACTED XBRL INSTANCE DOCUMENT myov-20210211_htm.xml XML 11676
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37929 | Film No.: 21616623
SIC: 2834 Pharmaceutical Preparations